Reports for TEVA CANADA LIMITED

Company Name

TEVA CANADA LIMITED

Totals

Shortage reports

2697

Actual shortage: 241 (9%)
Anticipated shortage: 0 (0%)
Avoided shortage: 9 (0%)
Resolved: 2447 (91%)

Discontinuation Reports

250

To be discontinued: 3 (1%)
Discontinued: 247 (99%)
Reversed: 0 (0%)

Late reports

330 (11%)

Overdue reports

26 (11%)

Shortage reports
Brand name Strength Dosage Status Date Created Date Updated Reports
OCTREOTIDE FOR INJECTABLE SUSPENSION 30MG POWDER FOR SUSPENSION, SUSTAINED-RELEASE KIT Resolved 2022-08-18 2024-06-13 166975
TEVA-MIRTAZAPINE 30MG TABLET Resolved 2022-08-18 2022-09-08 167246
TEVA-MORPHINE SR 30MG TABLET (EXTENDED-RELEASE) Resolved 2022-12-01 2023-02-09 176854
TEVA-MIRTAZAPINE 30MG TABLET Resolved 2022-12-22 2023-04-28 179188
TEVA-MORPHINE SR 30MG TABLET (EXTENDED-RELEASE) Resolved 2022-12-22 2023-02-09 179303
TEVA-AMPHETAMINE XR 30MG CAPSULE (EXTENDED RELEASE) Resolved 2023-02-02 2023-09-07 183419
TEVA-MIRTAZAPINE 30MG TABLET Resolved 2023-06-08 2023-10-03 194100
TEVA-AMPHETAMINE XR 30MG CAPSULE (EXTENDED RELEASE) Resolved 2023-06-16 2023-07-05 195139
TEVA-MIRTAZAPINE 30MG TABLET Resolved 2023-06-19 2023-07-06 195509
TEVA-LANSOPRAZOLE 30MG CAPSULE (DELAYED RELEASE) Actual shortage 2023-06-19 2024-03-18 195649
TEVA-LANSOPRAZOLE 30MG CAPSULE (DELAYED RELEASE) Actual shortage 2023-06-20 2024-03-18 195879
TEVA-MORPHINE SR 30MG TABLET (EXTENDED-RELEASE) Resolved 2023-07-04 2023-08-04 197169
TEVA-MIRTAZAPINE 30MG TABLET Actual shortage 2023-10-05 2023-11-09 206407
TEVA-DULOXETINE 30MG CAPSULE (DELAYED RELEASE) Actual shortage 2023-10-05 2024-01-25 206431
TEVA-MIRTAZAPINE 30MG TABLET Resolved 2023-11-30 2024-01-19 211979
TEVA-DULOXETINE 30MG CAPSULE (DELAYED RELEASE) Actual shortage 2024-01-11 2024-06-07 215751
TEVA-RISEDRONATE 30MG TABLET Actual shortage 2024-01-18 2024-01-19 216497
TEVA-CINACALCET 30MG TABLET Actual shortage 2024-04-11 2024-06-13 224907
TEVA-MIRTAZAPINE 30MG TABLET Actual shortage 2024-05-09 2024-05-09 227480
ACT PIOGLITAZONE 30MG TABLET Actual shortage 2024-05-09 2024-05-09 227486

Showing 1821 to 1840 of 2697

Discontinuation reports
Brand name Strength Dosage Status Date Created Date Updated Reports
RATIO-ATORVASTATIN Discontinued 2018-10-17 2018-10-17 64626
RATIO-ATORVASTATIN Discontinued 2018-10-19 2018-10-19 64852
ACT CLOPIDOGREL Discontinued 2018-10-19 2018-10-19 65065
ACT TADALAFIL Discontinued 2018-10-22 2018-10-22 65284
ACT TADALAFIL Discontinued 2018-10-22 2018-10-22 65289
HYDROCORTISONE SODIUM SUCCINATE FOR INJECTION Discontinued 2019-04-11 2019-04-11 81330
HYDROCORTISONE SODIUM SUCCINATE FOR INJECTION Discontinued 2019-04-11 2019-04-11 81337
HYDROCORTISONE SODIUM SUCCINATE FOR INJECTION Discontinued 2019-04-11 2019-04-11 81344
HYDROCORTISONE SODIUM SUCCINATE INJECTION Discontinued 2019-04-11 2019-04-11 81347
TEVA-RANITIDINE Discontinued 2020-02-13 2020-02-13 106136
TEVA-RANITIDINE Discontinued 2020-02-13 2020-02-13 106139
RATIO-SALBUTAMOL Discontinued 2020-02-13 2020-02-13 106151
GEMCITABINE FOR INJECTION Discontinued 2020-02-13 2020-02-13 106155
EPTIFIBATIDE INJECTION Discontinued 2020-02-13 2020-02-13 106170
LINEZOLID INJECTION Discontinued 2020-02-13 2020-02-13 106173
EPTIFIBATIDE INJECTION Discontinued 2020-02-13 2020-02-13 106176
TEVA-TRAVOPROST Z OPHTHALMIC SOLUTION 0.004% SOLUTION Discontinued 2020-01-21 2020-01-21 103788
TEVA-ECTOSONE 0.1% LOTION Discontinued 2023-12-05 2023-12-05 212526
PIPERACILLIN / TAZOBACTAM POWDER FOR INJECTION 0.375G 3G POWDER FOR SOLUTION Discontinued 2023-11-15 2023-11-15 210191
RATIO-TAMSULOSIN 0.4MG CAPSULE (SUSTAINED-RELEASE) Discontinued 2018-10-19 2018-10-19 64917

Showing 21 to 40 of 250